Abstract
Decompressive hemicraniectomy (DC) is an established lifesaving treatment for malignant infarction of the middle cerebral artery (mMCAI). However, surgical decompression will not reverse the effects of the stroke and many survivors will be left severely disabled. The objective of this study was to assess what neurological outcome would be considered acceptable in these circumstances amongst Swedish healthcare workers. Healthcare workers were invited to participate in a presentation that outlined the pathophysiology of mMCAI, the rationale behind DC and outcome data from randomised controlled trials that have investigated efficacy of the procedure. They were then asked which neurological outcome would they feel to be acceptable based on the modified Rankin Score (mRS) and the Aphasia Handicap Scale (AHS). Information regarding sex, age, marital status, relatives, religion, earlier experience of stroke and occupation was also collected. Six hundred and nine persons participated. The median accepted mRS was 3. An mRS of 4 or 5 was perceived to be acceptable by only 30.5% of participants. Therefore the most likely outcome, based on the results of the randomised controlled trials, would be unacceptable to most of the participants [O...Continue Reading
References
Dec 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·B FarrellC Warlow
Feb 13, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·M HoltkampF Masuhr
Oct 17, 2002·Journal of Neurology·Georg LeonhardtHans Christoph Diener
Dec 24, 2004·Current Opinion in Critical Care·Christiane Druml
Aug 1, 2006·The American Journal of Psychiatry·Laura B DunnElyn R Saks
Feb 17, 2007·Lancet Neurology·Katayoun VahediUNKNOWN DECIMAL, DESTINY, and HAMLET investigators
Jun 22, 2007·Lancet Neurology·Volker PuetzUNKNOWN Calgary Stroke Program
Aug 11, 2007·Stroke; a Journal of Cerebral Circulation·Eric JüttlerUNKNOWN DESTINY Study Group
Aug 11, 2007·Stroke; a Journal of Cerebral Circulation·Katayoun VahediUNKNOWN DECIMAL Investigators
Feb 28, 2009·Neurocritical Care·David R LarachMarilyn Green Larach
Mar 10, 2009·Lancet Neurology·Jeannette HofmeijerUNKNOWN HAMLET investigators
May 15, 2013·Brain Injury : [BI]·S Honeybul, K M Ho
May 16, 2013·Journal of Neurology·C AzuarY Samson
Jun 13, 2013·Neurosurgery·Stephen HoneybulKwok Ho
Oct 15, 2013·Journal of Neurosurgery·Stephen HoneybulKwok M Ho
Feb 20, 2014·Neurocritical Care·Hermann NeugebauerEric Jüttler
Mar 22, 2014·The New England Journal of Medicine·Eric JüttlerUNKNOWN DESTINY II Investigators
Dec 18, 2014·The New England Journal of Medicine·Olvert A BerkhemerUNKNOWN MR CLEAN Investigators
Feb 12, 2015·The New England Journal of Medicine·Mayank GoyalUNKNOWN ESCAPE Trial Investigators
Aug 6, 2015·Stroke; a Journal of Cerebral Circulation·Stephen HoneybulGrant Gillett
Nov 20, 2015·Neurosurgery·Stephen HoneybulDavid W Blacker
Feb 20, 2016·Stroke; a Journal of Cerebral Circulation·Fahad S Al-AjlanUNKNOWN ESCAPE Trial Investigators
Dec 15, 2016·Neurocritical Care·Hermann NeugebauerUNKNOWN IGNITE Study Group (Initiative of German NeuroIntensive Trial Engagement)
Citations
Aug 4, 2018·Neurocritical Care·Hermann NeugebauerUNKNOWN IGNITE Study Group (Initiative of German NeuroIntensive Trial Engagement)
Oct 2, 2019·Current Opinion in Critical Care·Jeroen T J M van DijckUNKNOWN all focus group participants
Feb 23, 2020·Expert Review of Neurotherapeutics·Stephen Honeybul
Jul 25, 2019·Frontiers in Neurology·Johann Otto PelzDominik Michalski
Dec 23, 2020·Journal of the Neurological Sciences·Mohamed AlzayianiWalid Albanna
Apr 16, 2021·Clinical Neurology and Neurosurgery·Roland RoelzChristian Scheiwe
Dec 1, 2020·Journal of Neurosurgical Sciences·Friedrich MroskPeter Vajkoczy